Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 10 04:00PM ET
21.82
Dollar change
+0.72
Percentage change
3.41
%
Index- P/E39.24 EPS (ttm)0.56 Insider Own83.71% Shs Outstand272.77M Perf Week-17.50%
Market Cap5.95B Forward P/E30.56 EPS next Y0.71 Insider Trans0.00% Shs Float49.48M Perf Month-24.76%
Income147.55M PEG9.39 EPS next Q0.12 Inst Own14.82% Short Float5.62% Perf Quarter-33.07%
Sales1.17B P/S5.07 EPS this Y-5.35% Inst Trans-0.02% Short Ratio5.88 Perf Half Y-21.34%
Book/sh5.27 P/B4.14 EPS next Y20.95% ROA6.89% Short Interest2.78M Perf Year-20.86%
Cash/sh0.74 P/C29.58 EPS next 5Y4.18% ROE11.54% 52W Range20.01 - 36.30 Perf YTD-20.04%
Dividend Est.0.06 (0.26%) P/FCF- EPS past 5Y37.59% ROI8.48% 52W High-39.89% Beta0.67
Dividend TTM0.06 (0.26%) Quick Ratio1.35 Sales past 5Y18.75% Gross Margin28.80% 52W Low9.05% ATR (14)1.77
Dividend Ex-DateJun 07, 2023 Current Ratio1.92 EPS Y/Y TTM-0.91% Oper. Margin16.13% RSI (14)26.98 Volatility8.93% 5.54%
Employees- Debt/Eq0.28 Sales Y/Y TTM11.87% Profit Margin12.57% Recom1.64 Target Price30.85
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q-32.81% Payout- Rel Volume5.10 Prev Close21.10
Sales Surprise0.26% EPS Surprise-28.21% Sales Q/Q0.31% EarningsMay 09 BMO Avg Volume472.74K Price21.82
SMA20-20.25% SMA50-25.13% SMA200-26.59% Trades Volume2,410,869 Change3.41%
Date Action Analyst Rating Change Price Target Change
Apr-22-24Initiated Exane BNP Paribas Outperform
Nov-01-23Downgrade Jefferies Buy → Hold $39 → $29
Sep-26-23Initiated Stephens Overweight $33
Sep-19-23Initiated CJS Securities Market Outperform
Aug-24-23Downgrade Morgan Stanley Overweight → Equal-Weight $34
Aug-10-21Initiated Wells Fargo Overweight $24
Aug-10-21Initiated Morgan Stanley Overweight $26
Aug-10-21Initiated KeyBanc Capital Markets Overweight $27
Aug-10-21Initiated Jefferies Buy $25
Aug-10-21Initiated Citigroup Buy $27
May-10-24 12:44AM
May-09-24 12:45PM
10:53AM
09:16AM
08:52AM
08:41AM Loading…
08:41AM
07:34AM
06:46AM
06:39AM
May-01-24 04:30PM
Apr-25-24 04:04PM
10:02AM
Apr-22-24 06:08PM
Apr-06-24 08:37PM
Apr-04-24 08:00AM
07:21AM Loading…
Apr-01-24 07:21AM
Mar-29-24 04:51AM
Mar-26-24 04:10PM
Mar-21-24 11:45PM
Mar-20-24 05:12PM
Mar-12-24 07:37AM
Mar-11-24 05:05PM
Mar-08-24 02:35PM
Mar-07-24 11:33PM
06:49AM
06:30AM
Mar-05-24 08:01AM
Feb-22-24 04:30PM
Feb-17-24 06:56AM
Jan-24-24 08:00AM
06:43AM Loading…
Jan-22-24 06:43AM
Jan-03-24 04:30PM
Dec-27-23 08:15AM
Dec-01-23 06:32AM
Nov-16-23 06:00AM
Nov-09-23 06:30AM
Nov-01-23 09:13AM
Oct-31-23 07:50AM
06:41AM
06:30AM
Oct-27-23 11:40AM
Oct-26-23 10:02AM
Oct-24-23 10:00AM
Oct-17-23 04:05PM
Oct-11-23 11:40AM
Oct-05-23 04:05PM
Sep-19-23 04:07PM
Sep-14-23 11:40AM
Sep-11-23 12:00PM
Aug-21-23 02:30AM
Jul-29-23 11:11AM
Jul-28-23 09:45AM
08:35AM
06:30AM
Jul-18-23 06:47AM
Jul-14-23 04:05PM
Jul-11-23 06:05PM
Jun-19-23 03:49AM
Jun-16-23 08:12AM
Jun-12-23 08:00AM
Jun-08-23 08:14AM
Jun-07-23 12:30PM
May-25-23 04:01AM
May-24-23 04:01PM
May-06-23 08:09AM
May-05-23 11:23AM
May-04-23 08:05AM
06:51AM
06:31AM
May-02-23 06:30AM
May-01-23 10:01AM
Apr-27-23 10:02AM
Apr-18-23 09:15AM
Apr-17-23 04:30PM
Apr-13-23 12:37PM
Mar-31-23 11:03AM
Mar-30-23 09:15AM
Mar-21-23 06:30AM
Mar-16-23 08:00AM
Mar-14-23 06:00AM
Mar-08-23 12:30PM
Mar-07-23 12:20PM
Mar-06-23 10:00AM
Mar-04-23 07:43AM
Mar-03-23 03:53AM
Mar-02-23 11:05AM
06:30AM
Feb-28-23 10:15AM
Feb-27-23 07:55PM
Feb-24-23 06:27AM
Feb-16-23 04:45PM
Jan-24-23 08:00AM
Jan-03-23 08:58AM
Dec-07-22 05:01AM
Nov-10-22 04:01PM
06:43AM
Nov-08-22 07:55AM
06:30AM
Nov-01-22 11:23AM
Oct-27-22 08:01AM
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.